Clinical trial
Collecting, Analyzing, and Storing Samples From Patients With Metastatic, Triple Negative Breast Cancer Receiving Anti-cancer Therapy
NCT01957514
Study timeline
Study start (actual)2013-10-28Date precision: day
Registry last updated2021-09-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Estrogen Receptor Negativeunresolved
HER2/Neu Negativeunresolved
Progesterone Receptor Negativeunresolved
Stage IV Breast Cancer AJCC v6 and v7unresolved
Triple-Negative Breast Carcinomaunresolved
Interventions
Sponsors & collaborators
University of Washingtonlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01957514 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.